These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24175241)

  • 21. Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review.
    Wu PY; Lee SY; Chang KV; Chao CT; Huang JW
    Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
    Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calciprotein particle counts associate with vascular remodelling in chronic kidney disease.
    Feenstra L; Reijrink M; Pasch A; Smith ER; Visser LM; Bulthuis M; Lodewijk ME; Mastik MF; Greuter MJW; Slart RHJA; Mulder DJ; Pol RA; Te Velde-Keyzer CA; ; Krenning G; Hillebrands JL
    Cardiovasc Res; 2024 Aug; ():. PubMed ID: 39102822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular calcification in chronic renal failure.
    Tomson C
    Nephron Clin Pract; 2003; 93(4):c124-30. PubMed ID: 12759580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease.
    Lee SM; An WS
    Korean J Intern Med; 2019 May; 34(3):459-469. PubMed ID: 31048656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor.
    Masumoto A; Sonou T; Ohya M; Yashiro M; Nakashima Y; Okuda K; Iwashita Y; Mima T; Negi S; Shigematsu T
    J Atheroscler Thromb; 2017 Jul; 24(7):716-724. PubMed ID: 27840385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
    Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
    J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular calcification score on plain radiographs of the feet as a predictor of peripheral arterial disease in patients with chronic kidney disease.
    An WS; Son YK; Kim SE; Kim KH; Yoon SK; Bae HR; Rha SH
    Int Urol Nephrol; 2010 Sep; 42(3):773-80. PubMed ID: 20041296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular calcification on plain radiographs is related with the severity of lesions detected by coronary angiography in dialysis patients.
    Nam HS; Lee SM; Jeong EG; Lee DY; Son YK; Kim SE; Chung SH; Cho YR; Park JS; Lee SW; Noh MH; An WS
    Tohoku J Exp Med; 2015 Feb; 235(2):135-44. PubMed ID: 25746157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.
    London GM; Marchais SJ; Guérin AP; Métivier F
    Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):525-31. PubMed ID: 16205470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
    Xu TH; Sheng Z; Li Y; Qiu X; Tian B; Yao L
    Life Sci; 2020 Nov; 261():118121. PubMed ID: 32693242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.
    Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z
    J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study.
    Liu ZH; Yu XQ; Yang JW; Jiang AL; Liu BC; Xing CY; Lou JZ; Wang M; Cheng H; Liu J; Fu JZ; Zhang AH; Zhang M; Zhou QL; Yu C; Wang R; Wang L; Chen YQ; Guan TJ; Peng A; Chen N; Hao CM; Cheng XY;
    Curr Med Res Opin; 2018 Aug; 34(8):1491-1500. PubMed ID: 29672176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lowering vascular calcification burden in chronic kidney disease: Is it possible?
    Disthabanchong S
    World J Nephrol; 2013 Aug; 2(3):49-55. PubMed ID: 24255887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Vitamin K in Vascular Calcification.
    Cozzolino M; Fusaro M; Ciceri P; Gasperoni L; Cianciolo G
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):437-444. PubMed ID: 31831122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
    Hruska KA; Mathew S; Davies MR; Lund RJ
    Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
    Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
    BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND;
    Am J Nephrol; 2020; 51(3):201-215. PubMed ID: 32023606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors.
    Leckstroem DC; Bhuvanakrishna T; McGrath A; Goldsmith DJ
    Int Urol Nephrol; 2014 Jan; 46(1):63-70. PubMed ID: 23783567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.